The Curiox C- Free Pluto ALPHA replaces traditional centrifuge-based methods, offering a low-maintenance solution that eliminates bulky hardware. Utilizing a pipette head, it delivers gentle, ...

First master licensing framework for Pluto Code enables a global pharmaceutical organization to expand centrifuge-free automation across its liquid-handling infrastructure without repeated contracting ...

The share price of Curiox Biosystems has surged significantly this year. Despite expectations of a large operating loss again this year, the company's corporate value is rising on the back of strong ...

Curiox Biosystems Co. Ltd. Curiox Biosystems Co., Ltd. engages in the sale of automated equipment and consumables for cell analysis processes. Its products include cell pre-processing automation ...

BOSTON, Sept. 13, 2023 /PRNewswire/ -- Curiox Biosystems, a global leader in providing innovative and automated sample preparation solutions for accurate and reproducible cell analysis, is pleased to ...

Get an overview of the most important figures from each Curiox BioSystems financial report, including the income statement, balance sheet and cash flow statement, along with key financial ratios.

WOBURN, Mass., April 21, 2026 (GLOBE NEWSWIRE)-- Curiox Biosystems today announced the signing of a Master Software License Agreement with a major global pharmaceutical organization for the deployment ...

Find the Curiox BioSystems financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers from key financial reports, including the ...

Aaaaa Aaa 1,547.0 +29.57% 2,004.4 ...

Determining whether Curiox BioSystems Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current ...